Herantis Pharma Oyj (HEL: HRTIS)

Market Cap	29.94M
Revenue (ttm)	n/a
Net Income (ttm)	-612.16K
Shares Out	20.16M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,146
Open	1.535
Previous Close	1.485
Day's Range	1.485 - 1.535
52-Week Range	1.170 - 1.925
Beta	0.35
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 13, 2024

About Herantis Pharma Oyj

Herantis Pharma Oyj, a biotech company, engages in the development of disease-modifying cerebral dopamine neurotrophic factor (CDNF) based therapies for Parkinson’s disease (PD). Its lead product in pipeline includes HER-096, an advanced small synthetic chemical peptidomimetic molecule developed based on the active site of the CDNF protein for the treatment of PD and other neurodegenerative diseases. The company was incorporated in 2008 and is based in Espoo, Finland.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 10
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: HRTIS